Life Sciences has emerged as one of the newest and most exciting industries to take root in Chattanooga in recent years. Over the past decade, and especially in recent years, Chattanooga has witnessed the birth and growth of several medical device and biopharmaceutical start-up and development stage companies. The attorneys at Evans Harrison Hackett have been instrumental in helping to establish Life Sciences as a viable industry in the Chattanooga area, and we have been closely involved in the growth of this industry in this area every step of the way. As a result, we have developed a broad range of experience in the Life Sciences field.
We have handled a myriad of Life Sciences transactions, including in-licensing and out-licensing of technology; formation and dissolution of strategic alliances such as co-development agreements, joint ventures, co-promotion agreements, and partnerships; domestic and international distribution agreements; clinical trial contracting, material transfer agreements and data use agreements; product sales agreements, product evaluation agreements and GPO contracting; sales and marketing agreements; and manufacturing and supply agreements.
We advise our clients on various regulatory matters, assisting with the determination of regulatory pathways for particular products, FDA clearance/approval of devices and drugs/biologics, orphan drug designations, and regulatory compliance programs for product promotion, sales and off-label use issues.
We also have substantial experience in assisting our clients in entity formation and corporate structure and the negotiation, structuring and documentation of angel investments, venture capital funding and other private placement financing at both the early round and follow-on stages of development.
We understand the unique challenges start-ups and development stage companies face, including limitations on resources and capital, and we help our clients develop a strategy and business plan to help maximize their chances of success.